$642 Million is the total value of First Light Asset Management, LLC's 55 reported holdings in Q2 2018. The portfolio turnover from Q1 2018 to Q2 2018 was 5.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| NEO | Buy | NEOGENOMICS INC | $67,675,000 | +74.2% | 5,162,063 | +8.4% | 10.54% | +23.5% |
| TNDM | Sell | TANDEM DIABETES CARE INC | $41,932,000 | +78.6% | 1,904,260 | -59.8% | 6.53% | +26.6% |
| ARRY | Buy | ARRAY BIOPHARMA INC | $40,131,000 | +46.8% | 2,391,575 | +42.8% | 6.25% | +4.1% |
| SHPG | Buy | SHIRE PLC | $38,777,000 | +44.2% | 229,721 | +27.6% | 6.04% | +2.3% |
| ATRC | Buy | ATRICURE INC | $37,340,000 | +55.8% | 1,380,405 | +18.2% | 5.81% | +10.5% |
| OMCL | Buy | OMNICELL INC | $34,937,000 | +138.1% | 666,109 | +97.0% | 5.44% | +68.8% |
| HRTX | Buy | HERON THERAPEUTICS INC | $32,507,000 | +148.9% | 836,737 | +76.8% | 5.06% | +76.5% |
| HBIO | Buy | HARVARD BIOSCIENCE INC | $31,838,000 | +17.0% | 5,951,014 | +9.4% | 4.96% | -17.0% |
| IMMU | Buy | IMMUNOMEDICS INC | $27,398,000 | +83.9% | 1,157,498 | +13.5% | 4.27% | +30.4% |
| LGND | Buy | LIGAND PHARMACEUTICALS INC | $25,371,000 | +31.5% | 122,463 | +4.8% | 3.95% | -6.8% |
| MODN | Buy | MODEL N INC | $24,923,000 | +29.0% | 1,339,922 | +25.2% | 3.88% | -8.5% |
| XNCR | Sell | XENCOR INC | $20,792,000 | -0.6% | 561,807 | -19.5% | 3.24% | -29.5% |
| IONS | Buy | IONIS PHARMACEUTICALS INC | $20,599,000 | +1000.4% | 494,347 | +1064.2% | 3.21% | +680.3% |
| NKTR | Buy | NEKTAR THERAPEUTICS | $18,275,000 | -42.7% | 374,251 | +24.7% | 2.84% | -59.4% |
| OXFD | Buy | OXFORD IMMUNOTEC GLOBAL PLC | $15,989,000 | +105.0% | 1,240,391 | +98.0% | 2.49% | +45.3% |
| CSII | Buy | CARDIOVASCULAR SYSTEMS INC | $15,756,000 | +53.0% | 487,207 | +3.7% | 2.45% | +8.4% |
| HALO | Buy | HALOZYME THERAPEUTICS INC | $15,010,000 | +52.3% | 889,729 | +76.9% | 2.34% | +8.0% |
| CDXS | Buy | CODEXIS INC | $12,116,000 | +73.8% | 841,419 | +32.8% | 1.89% | +23.2% |
| NVRO | Sell | NEVRO CORP | $9,280,000 | -35.8% | 116,224 | -30.3% | 1.44% | -54.5% |
| XENT | Buy | INTERSECT ENT INC | $8,534,000 | +14.8% | 227,883 | +20.4% | 1.33% | -18.6% |
| DVAX | Buy | DYNAVAX TECHNOLOGIES CORP | $8,369,000 | -7.1% | 548,777 | +21.0% | 1.30% | -34.1% |
| VCYT | Buy | VERACYTE INC | $8,238,000 | +74.4% | 881,983 | +3.8% | 1.28% | +23.7% |
| NVTRQ | Sell | NUVECTRA CORP | $7,868,000 | +46.1% | 383,245 | -7.3% | 1.22% | +3.6% |
| KTWO | Buy | K2M GROUP HOLDINGS INC | $6,573,000 | +26.1% | 292,143 | +6.2% | 1.02% | -10.7% |
| TECH | Buy | BIO TECHNE CORP | $6,079,000 | +4.1% | 41,089 | +6.3% | 0.95% | -26.2% |
| BMRN | Buy | BIOMARIN PHARMACEUTICAL INC | $5,911,000 | +128.9% | 62,750 | +97.0% | 0.92% | +62.3% |
| QDEL | Buy | QUIDEL CORP | $5,370,000 | +36.3% | 80,755 | +6.2% | 0.84% | -3.4% |
| GMED | Sell | GLOBUS MEDICAL INC | $5,279,000 | -40.9% | 104,615 | -41.6% | 0.82% | -58.1% |
| BLUE | Buy | BLUEBIRD BIO INC | $5,236,000 | +20.6% | 33,360 | +31.3% | 0.82% | -14.5% |
| LHCG | Sell | LHC GROUP INC | $4,653,000 | +5.0% | 54,360 | -24.5% | 0.72% | -25.6% |
| NXTM | Sell | NXSTAGE MEDICAL INC | $4,253,000 | -11.5% | 152,448 | -21.1% | 0.66% | -37.3% |
| VRTX | Buy | VERTEX PHARMACEUTICALS INC | $4,245,000 | +11.2% | 24,974 | +6.6% | 0.66% | -21.1% |
| TLGT | Buy | TELIGENT INC | $3,983,000 | +7.7% | 1,151,032 | +4.6% | 0.62% | -23.6% |
| KIDS | Buy | ORTHOPEDIATRICS CORP | $3,306,000 | +88.9% | 124,108 | +6.8% | 0.52% | +34.1% |
| HSTM | Sell | HEALTHSTREAM INC | $2,503,000 | -54.5% | 91,635 | -58.7% | 0.39% | -67.7% |
| STRM | Sell | STREAMLINE HEALTH SOLUTIONS | $2,431,000 | -30.4% | 1,724,165 | -9.1% | 0.38% | -50.7% |
| IBB | ISHARES NASDAQ BIOTECHNOLOGY ETFetf | $2,338,000 | +2.9% | 21,291 | 0.0% | 0.36% | -27.1% | |
| PSCH | POWERSHARES S&P SMALLCAP HEALTH CARE ETFetf | $2,221,000 | +15.3% | 17,285 | 0.0% | 0.35% | -18.2% | |
| SGMO | New | SANGAMO THERAPEUTICS INC | $2,206,000 | – | 155,348 | +100.0% | 0.34% | – |
| LMAT | Buy | LEMAITRE VASCULAR INC | $1,674,000 | -1.5% | 49,996 | +6.6% | 0.26% | -30.0% |
| IHI | ISHARES US MEDICAL DEVICES ETFetf | $1,521,000 | +8.5% | 7,580 | 0.0% | 0.24% | -23.1% | |
| XLV | HEALTH CARE SELECT SECTOR SPDR ETFetf | $1,522,000 | +2.5% | 18,241 | 0.0% | 0.24% | -27.3% | |
| IRIX | Sell | IRIDEX CORP | $1,382,000 | -37.7% | 198,581 | -48.8% | 0.22% | -55.9% |
| ALKS | Buy | ALKERMES PLC | $1,328,000 | -24.2% | 32,271 | +6.8% | 0.21% | -46.2% |
| CELG | Buy | CELGENE CORP | $1,171,000 | -5.3% | 14,742 | +6.4% | 0.18% | -32.8% |
| ENZ | Sell | ENZO BIOCHEM INC | $984,000 | -28.4% | 189,600 | -24.5% | 0.15% | -49.3% |
| ABBV | ABBVIE | $385,000 | -2.3% | 4,159 | 0.0% | 0.06% | -31.0% | |
| DYNT | Buy | DYNATRONICS CORP | $313,000 | -2.5% | 108,885 | +1.8% | 0.05% | -30.0% |
| PFE | PFIZER INC | $310,000 | +2.0% | 8,558 | 0.0% | 0.05% | -28.4% | |
| SNY | SANOFI-SYNTHELABO | $269,000 | 0.0% | 6,720 | 0.0% | 0.04% | -28.8% | |
| NVS | NOVARTIS A G | $270,000 | -6.6% | 3,572 | 0.0% | 0.04% | -33.3% | |
| JNJ | JOHNSON AND JOHNSON | $265,000 | -5.4% | 2,183 | 0.0% | 0.04% | -32.8% | |
| MRK | MERCK & CO INC | $261,000 | +11.5% | 4,294 | 0.0% | 0.04% | -19.6% | |
| TFX | New | TELEFLEX INCORPORATED | $210,000 | – | 783 | +100.0% | 0.03% | – |
| AMGN | New | AMGEN INC | $204,000 | – | 1,105 | +100.0% | 0.03% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ATRICURE INC | 40 | Q3 2023 | 9.7% |
| NEOGENOMICS INC | 40 | Q3 2023 | 10.6% |
| SANOFI-SYNTHELABO | 40 | Q3 2023 | 1.9% |
| JOHNSON & JOHNSON | 40 | Q3 2023 | 0.3% |
| PFIZER INC | 39 | Q2 2023 | 0.9% |
| BIOMARIN PHARMACEUTICAL INC | 36 | Q3 2023 | 1.6% |
| OMNICELL INC | 33 | Q3 2023 | 7.7% |
| QUIDEL CORP | 33 | Q4 2021 | 3.7% |
| NOVARTIS AG-SPONSORED ADR | 33 | Q3 2023 | 0.4% |
| MODEL N INC | 30 | Q3 2023 | 9.0% |
View First Light Asset Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| REATA PHARMACEUTICALS INC | May 15, 2023 | 1,290,193 | 3.9% |
| Axogen, Inc. | February 03, 2023 | 1,942,270 | 4.6% |
| MODEL N, INC. | February 03, 2023 | 1,845,134 | 4.9% |
| MEI Pharma, Inc.Sold out | May 31, 2022 | 0 | 0.0% |
| PROTHENA CORP PUBLIC LTD CO | March 01, 2022 | 1,805,038 | 3.9% |
| Intersect ENT, Inc. | February 14, 2022 | 1,375,210 | 4.1% |
| SeaSpine Holdings Corp | February 14, 2022 | 6,847,707 | 18.8% |
| Oxford Immunotec Global PLCSold out | February 10, 2021 | 0 | 0.0% |
| ENDOLOGIX INC /DE/ | February 14, 2020 | 816,236 | 4.6% |
| Nuvectra CorpSold out | February 14, 2020 | 0 | 0.0% |
View First Light Asset Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-04-09 |
| 4 | 2024-04-08 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
View First Light Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.